Market Closed -
Nyse
04:00:03 2024-05-31 pm EDT
|
5-day change
|
1st Jan Change
|
1.4
USD
|
+6.06%
|
|
-6.67%
|
+248.26%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
42.08
|
39.25
|
55.03
|
35.12
|
112.8
|
930.3
|
-
|
-
|
Enterprise Value (EV)
1 |
42.08
|
39.25
|
55.03
|
35.12
|
112.8
|
930.3
|
930.3
|
930.3
|
P/E ratio
|
-7.81
x
|
-9
x
|
-12.9
x
|
-4.94
x
|
-2.36
x
|
-14
x
|
-12.7
x
|
-12.5
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
5.75
x
|
4.06
x
|
5.47
x
|
9.89
x
|
78.7
x
|
1,779
x
|
2,895
x
|
2,214
x
|
EV / Revenue
|
5.75
x
|
4.06
x
|
5.47
x
|
9.89
x
|
78.7
x
|
1,779
x
|
2,895
x
|
2,214
x
|
EV / EBITDA
|
-8,302,505
x
|
-13,682,309
x
|
-19,149,179
x
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-2.97
x
|
-14.8
x
|
-14.1
x
|
-26
x
|
FCF Yield
|
-
|
-
|
-
|
-
|
-33.7%
|
-6.78%
|
-7.1%
|
-3.85%
|
Price to Book
|
5.45
x
|
5.42
x
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
67,388
|
87,232
|
141,915
|
142,113
|
280,571
|
674,145
|
-
|
-
|
Reference price
2 |
0.6244
|
0.4500
|
0.3878
|
0.2471
|
0.4020
|
1.380
|
1.380
|
1.380
|
Announcement Date
|
9/24/19
|
9/17/20
|
9/21/21
|
5/1/23
|
3/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
7.314
|
9.68
|
10.05
|
3.552
|
1.434
|
0.523
|
0.3214
|
0.4202
|
EBITDA
|
-5.068
|
-2.869
|
-2.874
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-5.254
|
-3.549
|
-3.446
|
-
|
-40.94
|
-56.25
|
-63.86
|
-68.93
|
Operating Margin
|
-71.83%
|
-36.66%
|
-34.28%
|
-
|
-2,855.02%
|
-10,755.64%
|
-19,868.54%
|
-16,401.43%
|
Earnings before Tax (EBT)
1 |
-5.144
|
-3.446
|
-3.387
|
-
|
-40.11
|
-54.54
|
-64.26
|
-68.14
|
Net income
1 |
-5.155
|
-3.457
|
-3.39
|
-
|
-46.51
|
-54.63
|
-64.26
|
-68.14
|
Net margin
|
-70.48%
|
-35.71%
|
-33.72%
|
-
|
-3,243.24%
|
-10,444.97%
|
-19,994.84%
|
-16,214.1%
|
EPS
2 |
-0.0800
|
-0.0500
|
-0.0300
|
-0.0500
|
-0.1700
|
-0.0983
|
-0.1083
|
-0.1100
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-37.98
|
-63.05
|
-66.09
|
-35.77
|
FCF margin
|
-
|
-
|
-
|
-
|
-2,648.88%
|
-12,056.21%
|
-20,562.23%
|
-8,512.31%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
9/24/19
|
9/17/20
|
9/21/21
|
5/1/23
|
3/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
2.6
|
2.71
|
2.063
|
2.088
|
1.909
|
-4.902
|
0.325
|
0.0664
|
0.0676
|
0.069
|
0.107
|
EBITDA
|
-0.721
|
-0.916
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-0.766
|
-1.093
|
-
|
-11.37
|
-10.53
|
-7.806
|
-13
|
-13.86
|
-14.39
|
-15
|
-15.18
|
Operating Margin
|
-29.46%
|
-40.33%
|
-
|
-544.73%
|
-551.81%
|
159.24%
|
-4,001.54%
|
-20,867.47%
|
-21,294.01%
|
-21,735.14%
|
-14,191.12%
|
Earnings before Tax (EBT)
1 |
-0.745
|
-1.061
|
-
|
-11.11
|
-10.36
|
-7.773
|
-12.28
|
-13.59
|
-14
|
-14.63
|
-15.18
|
Net income
1 |
-0.745
|
-1.061
|
-
|
-11.11
|
-10.36
|
-24.68
|
-12.28
|
-13.59
|
-14
|
-14.63
|
-15.18
|
Net margin
|
-28.65%
|
-39.15%
|
-
|
-531.9%
|
-542.48%
|
503.37%
|
-3,779.69%
|
-20,462.95%
|
-20,708.28%
|
-21,202.32%
|
-14,188.79%
|
EPS
2 |
-0.0100
|
-0.0100
|
-
|
-0.0400
|
-0.0400
|
-0.0900
|
-0.0200
|
-0.0200
|
-0.0220
|
-0.0220
|
-0.0250
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/13/21
|
9/21/21
|
5/15/23
|
8/11/23
|
11/14/23
|
3/28/24
|
5/15/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-38
|
-63.1
|
-66.1
|
-35.8
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
0.1100
|
0.0800
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
0.44
|
0.27
|
-
|
-
|
1.07
|
3.71
|
1.06
|
1.08
|
Capex / Sales
|
6.07%
|
2.82%
|
-
|
-
|
74.76%
|
709.11%
|
330.02%
|
257.07%
|
Announcement Date
|
9/24/19
|
9/17/20
|
9/21/21
|
5/1/23
|
3/28/24
|
-
|
-
|
-
|
Last Close Price
1.38
USD Average target price
2.26
USD Spread / Average Target +63.77% Consensus |
1st Jan change
|
Capi.
|
---|
| +248.26% | 930M | | +43.36% | 54.63B | | -5.31% | 39.92B | | +37.52% | 38.82B | | +14.75% | 26.86B | | -12.56% | 26.22B | | -22.45% | 18.78B | | +25.12% | 12.21B | | +0.04% | 12.16B | | +26.04% | 11.94B |
Other Biotechnology & Medical Research
|